Nature Communications

A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD

2025-08-12

Full text

DOI https://doi.org/10.1038/s41467-025-62891-8